FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

Management:

Sysmex Europe GmbH

President & CEO: Dr. Jürgen Schulze, Hamburg-Norderstedt 
Managing Director: Fernando Andreu, Hamburg-Norderstedt
Managing Director: Takeshi Kubota, Hamburg-Norderstedt 
Managing Director: Iwane Matsui, Kobe, Japan 
Managing Director: Kazuya Obe, Kobe, Japan 
Managing Director: Dr. Michael Schaefer, Hamburg-Norderstedt
Managing Director: Matthias Völkel, Hamburg-Norderstedt
(Authorised representative: Marie Aldag)

Sysmex Middle East

Managing Director Sysmex Middle East: Saad Kayali
Director Sales & Marketing: Osama Ali
Director Customer Service: Hussam Shehadeh
Director Integrated Concept Solutions: Ayman Dallal
Director SCM, HR & Administration/SCM: Lina Habib

How can we help you?

Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
SUSPECTED HUS IN ROUTINE ANALYSIS
See the Podcast
See our collection